Boston Scientific won't get new stent patent trial

Boston Scientific Corp., the Natick medical device company, said an appeals court denied its request for a new trial of a patent case brought by Johnson & Johnson.

Late Monday, Boston Scientific said the United States District Court in Delaware granted Johnson & Johnson's motion for entry of final judgment, and refused to allow a new trial. In 2000, Boston Scientific said a jury found the company had violated a patent on the NIR stent, and awarded Johnson & Johnson $324 million.

A final judgment will be entered on Sept. 30.

Boston Scientific no longer sells the NIR stent.

Shares of Boston Scientific fell 30 cents, or 2.3 percent, to $12.89 on the New York Stock Exchange, while Johnson & Johnson added 18 cents to $69.79. (AP)